Quoin Pharmaceuticals, Ltd.

NASDAQ: QNRX · Healthcare · Biotechnology

PublicHQ Ashburn, VA · LoudounCIK 0001671502Reports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

38D

FH 39DQ 38GM —SS 34

v0.1 · 55/100 weight · provisional

↑ filing timeliness, balance-sheet leverage · ↓ disclosure history, workforce scale

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$15.8M

Employees

Market cap

$9.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02021

Net income-$15.8M-$15.8M2025

Total assets$20.4M$20.4M2025

Liabilities$7.3M$7.3M2025

Equity$13.1M$13.1M2025

Revenue trend

FY2021 – FY2021 · USD

FY21

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Quoin Pharmaceuticals, Ltd. booked $0 in FY2021 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

1CM Inc.70B Qscreen Ai Inc.——Medicus Pharma Ltd. Common Stock——PharmaCielo Ltd.40D

Neighbors

Loudoun →

DXC Technology Company$12.6B67B Telos Corporation$164.8M55C Critical Solutions, Inc.——Futuris Company——Reach Messaging Holdings, Inc.——Red Branch Technologies, Inc.$0——

Key facts

CEOMichael Myers

SectorHealthcare

IndustryBiotechnology

HeadquartersAshburn, VA

ExchangeNASDAQ: QNRX

Employees3

IPO date2016-08-01

Latest filings

8-K2026-06-23 8-K2026-06-04 8-K2026-05-07 10-Q2026-05-07 10-K2026-03-26 8-K2026-03-26 8-K2026-03-11 8-K2026-01-20

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.